Earnings Feed
Start Free
Home/Filings/4/A/0001193805-17-003506
4/A//SEC Filing

Biotest AG 4/A

Accession 0001193805-17-003506

CIK 0001368514other
View on SEC.govCompany Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 9:32 PM ET

Size

7.9 KB

Accession

0001193805-17-003506

Insider Transaction Report

Form 4/AAmended
Period: 2017-11-09
ADMA BIOLOGICS, INC.ADMA
Biotest AG
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2017-11-09$2.15/sh+5,813,954$12,500,001→ 10,109,534 total(indirect: By Biotest Pharmaceuticals Corporation)
Holdings

  • Non-Voting Common Stock

    (indirect: By Biotest Pharmaceuticals Corporation)
    8,591,160
Biotest Pharmaceuticals Corp
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2017-11-09$2.15/sh+5,813,954$12,500,001→ 10,109,534 total(indirect: By Biotest Pharmaceuticals Corporation)
Holdings

  • Non-Voting Common Stock

    (indirect: By Biotest Pharmaceuticals Corporation)
    8,591,160
Footnotes (2)
  • [F1]Represents a purchase from the underwriters in the issuer's public offering.
  • [F2]The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer.

Documents

1 file

Issuer

ADMA BIOLOGICS, INC.

CIK 0001368514

→
Entity typeother
IncorporatedGermany

Related Parties

1
  • filerCIK 0001709152

Filing Metadata

Form type
4/A
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:32 PM ET
Size
7.9 KB
View on SEC.gov